Out of the darkness: new gene therapies for eye diseases

Tuesday, October 24, 2017

Chief research officer at the Foundation Fighting Blindness, Dr. Stephen Rose, weighed in on FDA expert committee’s ‘yes’ that could pave the way for a new generation of gene therapies for rare inherited eye disorders. Dr. Rose said: “This is the first of what we believe will be many. It is a very important step forward; it gives real hope to individuals with other gene-directed inherited retinal diseases.” Read the full article on Pharma Phorum here.